Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription 15.07.2024 1 Ann Intern Med 1 Chest 7 Circulation 11 Eur Heart J 2 Int J Cardiol 12 J Cardiovasc Electrophysiol 6 J Interv Card Electrophysiol 2 J Thromb Thrombolysis 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
   Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
   Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
   PubMed         Abstract available
   
   

   
   Chest

2. O'MEARA K, Stone G, Buch E, Brownstein A, et al
   Atrial Arrhythmias in Patients with Pulmonary Hypertension.
   Chest. 2024 Mar 5:S0012-3692(24)00291-5. doi: 10.1016/j.chest.2024.
   PubMed         Abstract available
   
   

   
   Circulation

3. HEIJMAN J, Dobrev D
   Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns.
   Circulation. 2024;150:128-131.
   PubMed        
   
   
4. VAN DOORN S, Rutten FH, Geersing GJ
   Response by van Doorn et al to Letters Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled
   Circulation. 2024;150:e30-e32.
   PubMed        
   
   
5. KO D, Kim DH, Singer DE
   Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e25-e26.
   PubMed        
   
   
6. SUWA M, Morii I, Kino M
   Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e27.
   PubMed        
   
   
7. MILLIS CE, Feradov DF, Prida XE
   Letter by Millis et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e23-e24.
   PubMed        
   
   
8. LIN Y
   Letter by Lin Regarding Article, "Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e21-e22.
   PubMed        
   
   
9. KOHSAKA S, Nishimura S, Kumamaru H
   Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e28-e29.
   PubMed        
   
   

   
   Eur Heart J

10. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    PubMed        
    
    
11. WILDE AAM, van der Werf C
    Risk scores in congenital long QT syndrome: friend or foe?
    Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093.
    PubMed        
    
    
12. CONNORS JM
    Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm.
    Eur Heart J. 2024 Jul 12:ehae336. doi: 10.1093.
    PubMed        
    
    
13. CHOI YJ, Lim J, Bea S, Lee J, et al
    Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
    Eur Heart J. 2024 Jul 12:ehae335. doi: 10.1093.
    PubMed         Abstract available
    
    
14. KAJIHARA Y
    Edoxaban-induced oesophagitis.
    Eur Heart J. 2024;45:2460.
    PubMed        
    
    
15. AIRAKSINEN KEJ, De Sensi F
    Ten years of direct oral anticoagulants: lessons learned and challenges ahead.
    Eur Heart J. 2024;45:2178-2180.
    PubMed        
    
    
16. ISHIKAWA T, Masuda T, Hachiya T, Dina C, et al
    Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
    Eur Heart J. 2024;45:2320-2332.
    PubMed         Abstract available
    
    
17. SAVASTANO S, Baldi E, Rordorf R
    Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
    Eur Heart J. 2024;45:2264.
    PubMed        
    
    
18. SCACCIAVILLANI R
    Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
    Eur Heart J. 2024;45:2263.
    PubMed        
    
    
19. BEHR ER
    Brugada syndrome: can polygenic risk scores help the clinician?
    Eur Heart J. 2024;45:2333-2335.
    PubMed        
    
    
20. CREA F
    A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
    Eur Heart J. 2024;45:2267-2270.
    PubMed        
    
    

    
    Int J Cardiol

21. HEEGER CH, Alagjozovski H
    Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024;412:132299.
    PubMed        
    
    
22. GIOMI A, Bernardini A, Perini AP, Ciliberti D, et al
    Clinical impact of smoking on atrial fibrillation recurrence after pulmonary vein isolation.
    Int J Cardiol. 2024 Jul 4:132342. doi: 10.1016/j.ijcard.2024.132342.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Electrophysiol

23. QI D, Guan X, Liu X, Liu L, et al
    Relationship between sodium-glucose cotransporter 2 inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with type 2 diabetes and persistent atrial fibrillation.
    J Cardiovasc Electrophysiol. 2024 Jul 11. doi: 10.1111/jce.16369.
    PubMed         Abstract available
    
    
24. KATAOKA N, Imamura T
    Clinical indication of intramural needle ablation for scar-related ventricular tachycardia in the contemporary era.
    J Cardiovasc Electrophysiol. 2024;35:1511.
    PubMed        
    
    
25. VIVEKANANTHAM H, Mtwesi V, Divakara Menon SM
    Transformation of a tachycardia following a His-refractory premature ventricular complex: What is the mechanism?
    J Cardiovasc Electrophysiol. 2024;35:1498-1501.
    PubMed        
    
    
26. ZUPAN MEZNAR A, Mrak M, Mullens W, Stublar J, et al
    AV-optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross-over study.
    J Cardiovasc Electrophysiol. 2024;35:1340-1350.
    PubMed         Abstract available
    
    
27. KHAN MZ, Nassar S, Nguyen A, Khan MU, et al
    Contemporary trends of leadless pacemaker implantation in the United States.
    J Cardiovasc Electrophysiol. 2024;35:1351-1359.
    PubMed         Abstract available
    
    
28. NEARING BD, Fialho GL, Waks JW, Maher TR, et al
    P-wave alternans rebound following pulmonary vein isolation predicts atrial arrhythmia recurrence.
    J Cardiovasc Electrophysiol. 2024;35:1360-1367.
    PubMed         Abstract available
    
    
29. PARK JW, Ha YW, Park S, Choi Y, et al
    A supraventricular tachycardia and the response to double ventricular extrastimulus pacing: What is the mechanism?
    J Cardiovasc Electrophysiol. 2024;35:1502-1505.
    PubMed        
    
    
30. SALUJA D, Huang Z, Majumder J, Zeldin L, et al
    Automated prediction of isthmus areas in scar-related atrial tachycardias using artificial intelligence.
    J Cardiovasc Electrophysiol. 2024;35:1401-1411.
    PubMed         Abstract available
    
    
31. CABRERA JS, Tapias C, Adams C, Hernandez B, et al
    Intracardiac echocardiography guided anatomical ablation of the arcuate ridge for drug refractory inappropriate sinus tachycardia.
    J Cardiovasc Electrophysiol. 2024;35:1393-1400.
    PubMed         Abstract available
    
    
32. MI LJ, Weng SX, Sun Q, Zhang HD, et al
    Activation pattern of the coronary sinus facilitates the differentiation for ventricular outflow tract arrhythmias.
    J Cardiovasc Electrophysiol. 2024;35:1440-1449.
    PubMed         Abstract available
    
    
33. VIJAYARAMAN P, Foo D, Lim TSE, Diamantakos E, et al
    Result of the left bundle branch area pacing data collection registry, an international multicenter study of conduction system pacing with a Tendril STS 2088 stylet-driven lead.
    J Cardiovasc Electrophysiol. 2024;35:1452-1460.
    PubMed         Abstract available
    
    
34. NEIRA V, Hanson M, Tso M, Khakh P, et al
    Comparison of anterior mitral line and mitral isthmus line for ablation of mitral annular flutter.
    J Cardiovasc Electrophysiol. 2024;35:1480-1486.
    PubMed         Abstract available
    
    

    
    J Interv Card Electrophysiol

35. RUZIEH M, Bai C, Meisel E, Kramer EF, et al
    Predictors of left atrial appendage thrombus in atrial fibrillation patients undergoing cardioversion.
    J Interv Card Electrophysiol. 2024 Jul 12. doi: 10.1007/s10840-024-01868.
    PubMed         Abstract available
    
    
36. KREIMER F, Koepsel K, Gotzmann M, Kovacs B, et al
    Predictors of ventricular tachyarrhythmia in patients with a wearable cardioverter defibrillator: an international multicenter registry.
    J Interv Card Electrophysiol. 2024 Jul 10. doi: 10.1007/s10840-024-01869.
    PubMed         Abstract available
    
    
37. ARDASHEV A, Passman R, Efimov I, Rytkin E, et al
    Endovascular occlusion of patent foramen ovale as antiarrhythmic treatment of atrial fibrillation.
    J Interv Card Electrophysiol. 2024 Jul 9. doi: 10.1007/s10840-024-01860.
    PubMed        
    
    
38. MAZETTO RA, Antunes V, Bulhoes E, Defante M, et al
    Effect of catheter ablation versus medical therapy on mental health and quality of life in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
    J Interv Card Electrophysiol. 2024 Jul 9. doi: 10.1007/s10840-024-01861.
    PubMed         Abstract available
    
    
39. MAEDA S, Kawabata M, Kamata T, Hasebe Y, et al
    High-density visualization of antegrade fast pathway activation during atypical fast/slow atrioventricular nodal reentrant tachycardia in two cases.
    J Interv Card Electrophysiol. 2024 Jul 8. doi: 10.1007/s10840-024-01858.
    PubMed        
    
    
40. CALVERT P, Gupta D
    Response to "How to demonstrate the advantage of cryoballoon pulmonary vein isolation over cavotricuspid isthmus ablation in patients with typical atrial flutter".
    J Interv Card Electrophysiol. 2024 Jul 8. doi: 10.1007/s10840-024-01855.
    PubMed        
    
    

    
    J Thromb Thrombolysis

41. PETERSON ME, Jaynes MP, Berardi S, Morton C, et al
    Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal.
    J Thromb Thrombolysis. 2024;57:865-870.
    PubMed         Abstract available
    
    
42. KRITTAYAPHONG R, Winijkul A, Methavigul K, Chichareon P, et al
    Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study.
    J Thromb Thrombolysis. 2024 Jul 9. doi: 10.1007/s11239-024-03007.
    PubMed         Abstract available
    
    

    
    PLoS One

43. NAKAJIMA T, Haruyama A, Fukuda T, Minami K, et al
    Left atrial reservoir strain is a marker of atrial fibrotic remodeling in patients undergoing cardiovascular surgery: Analysis of gene expression.
    PLoS One. 2024;19:e0306323.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.